share_log

argenx SE | 6-K: argenx Announces FDA Acceptance of Supplemental Biologics License Application

SEC announcement ·  Feb 20 19:08
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.